sur ABIVAX (EPA:ABVX)
Helikon increases its investment in ABIVAX
Helikon Investments Limited, through its Helikon Long Short Equity Fund Master ICAV, recently increased its stake in ABIVAX. This fund crossed the 5% threshold of ABIVAX's share capital, holding 5.02% as of September 24, 2026, through a market acquisition.
On September 25, the fund further strengthened its position, reaching 5.16% of the share capital and 5.09% of the voting rights. This continued increase resulted in the fund holding 6.22% of the share capital, representing 6.13% of the voting rights, as of October 8, for a total of 5,426,529 shares.
The shares held also result from equity swap contracts, influencing the reported figures. These increases reflect Helikon's targeted investment strategy on ABIVAX.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ABIVAX